Cell transplantation improves ventricular function in the infarcted heart, suggesting benefits may arise from mechanisms distinct from true myocardial regeneration.
Substantial evidence indicates that cell transplantation can improve function of the infarcted heart. A surprisingly wide range of non-myogenic cell types improves ventricular function, suggesting that benefit may result in part from mechanisms that are distinct from true myocardial regeneration. While clinical trials explore cells derived from skeletal muscle and bone marrow, basic researchers are investigating sources of new cardiomyocytes, such as resident myocardial progenitors and embryonic stem cells. In this commentary, we briefly review the evolution of cell-based cardiac repair, discuss the current state of clinical research, and offer some thoughts on how newcomers can critically evaluate this emerging field.
Murry et al. (2006) conducted an editorial in Infarcted heart. Cell transplantation was evaluated. Cell transplantation improves ventricular function in the infarcted heart, suggesting benefits may arise from mechanisms distinct from true myocardial regeneration.